IESE (España)
-
Genmedi: How to Value a New Company for an Upcoming Round of Financing - Teaching Note
Liechtenstein, Heinrich; Kolarova, LenkaTeaching Note ET-34-EEntrepreneurship, FinanceEvery venture capital and private equity deal involves determining the value of the company. This is one of the most important-and most difficult-tasks faced by an investor (and an entrepreneur), and skill is required when using the various methods for valuing a company. In March 2019, the investors in LifeCycle Ltd.-a technology company based in Shanghai, China-set up a new company, Genmed, to capitalize on an innovative technology for biologica...Starting at €0.00
-
Kapoor's Portfolio
Canela, Miguel Ángel; Alegre, Inés; Moleskis, MelinaFocused Case ADFC-5-EDecision AnalysisThe case follows a trainee portfolio manager in her attempt to build an investment portfolio using stocks on India's National Stock Exchange (NSE). Within the framework of the capital asset pricing model, this note focuses on the computation of financial returns, risk and diversification strategies.Starting at €8.20
-
Visant Capital
Kelly, Peter; Liquido, Francisco; Liechtenstein, HeinrichCase E-168-EEntrepreneurshipDhruv is an Indian search fund entrepreneur. His is only the second search fund in India. More than a year into his search, he has finally found a company for acquisition and it is time to bring it to investors. Will they like the company? Or will he have to keep searching?Starting at €8.20
-
Genmedi: How to Value a New Company for an Upcoming Round of Financing
Liechtenstein, Heinrich; Kolarova, LenkaCase E-207-EEntrepreneurship, FinanceEvery venture capital and private equity deal involves determining the value of the company. This is one of the most important-and most difficult-tasks faced by an investor (and an entrepreneur), and skill is required when using the various methods for valuing a company. In March 2019, the investors in LifeCycle Ltd.-a technology company based in Shanghai, China-set up a new company, Genmed, to capitalize on an innovative technology for biologica...Starting at €8.20